BRIEF published on 10/28/2025 at 09:05, 1 month 7 days ago SANHA GmbH & Co. KG Reports Steady Revenue Growth Amid Challenging Market EBITDA Revenue Growth Financial Performance Market Expansion SANHA
PRESS RELEASE published on 10/28/2025 at 09:00, 1 month 7 days ago SANHA GmbH & Co. KG: Business performance on track with sustained profitability in the first nine months of 2025 SANHA GmbH & Co. KG reports sustained profitability with revenue up 1.9% to EUR 94.6 million in first nine months of 2025. EBITDA margin remains strong at 16.5% EBITDA Revenue Profitability 2025 SANHA GmbH & Co. KG
BRIEF published on 08/15/2025 at 09:05, 3 months 20 days ago SANHA GmbH & Co. KG Maintains Stable Earnings in H1 2025 Business Outlook International Sales Revenue Stability SANHA GmbH & Co. KG 2025 Financial Results
PRESS RELEASE published on 08/15/2025 at 09:00, 3 months 20 days ago SANHA GmbH & Co. KG reports solid business performance in the first half of 2025 SANHA GmbH & Co. KG reports stable business performance in the first half of 2025 with revenue at EUR 61.5 million. Gross profit increased, EBITDA margin slightly down. Outlook confirms stable performance Revenue EBITDA Margin Outlook Business Performance SANHA GmbH
BRIEF published on 04/30/2025 at 09:05, 7 months 4 days ago SANHA GmbH & Co. KG Reports Stable Growth in Q1 2025 Revenue Growth EBITDA Margin Quarterly Results SANHA GmbH & Co. KG International Diversification
PRESS RELEASE published on 04/30/2025 at 09:00, 7 months 4 days ago SANHA GmbH & Co. KG reports positive business performance in the first quarter of 2025 SANHA GmbH & Co. KG reports positive business performance with 3.5% revenue growth in Q1 2025. Revenues reach EUR 31.8 million, EBITDA rises to EUR 5.6 million, outlook for 2025 stable EBITDA Revenue Growth Business Performance Q1 2025 SANHA GmbH
BRIEF published on 04/17/2025 at 09:05, 7 months 17 days ago SANHA GmbH & Co. KG Sees Earnings Growth in 2024 Amid Tough Conditions EBITDA Sustainability Efficiency Earnings Growth 2025 Outlook
PRESS RELEASE published on 04/17/2025 at 09:00, 7 months 17 days ago SANHA GmbH & Co. KG reports further increase in earnings in the 2024 financial year SANHA GmbH & Co. KG reports a further increase in earnings in the 2024 financial year, with revenues up almost 2% to EUR 124.1 million and significant growth in gross profit and EBITDA margin Revenues EBITDA Earnings Increase 2024 Financial Year SANHA GmbH & Co. KG
BRIEF published on 03/17/2025 at 10:05, 8 months 18 days ago SANHA GmbH & Co. KG Completes Early Bond Repayment Refinancing Bond Repayment Financial Strategy Corporate Bond SANHA GmbH & Co. KG
PRESS RELEASE published on 03/17/2025 at 10:00, 8 months 18 days ago SANHA GmbH & Co. KG: 2013/2026 corporate bond has been repaid SANHA GmbH & Co. KG repays 2013/2026 corporate bond ahead of schedule, enabling diversified financing structure after successful refinancing negotiations Refinancing Repayment Corporate Bond SANHA GmbH & Co. KG 2013/2026
Published on 12/05/2025 at 02:35, 4 hours 17 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 52 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 47 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 52 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 22 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 2 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 27 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 37 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 42 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 52 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 7 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 8 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 51 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
